Product Description
CJC-1295 NO DAC | 5mg + Ipamorelin | 5mg
Researching Growth Hormone Signaling and Recovery
What It Does
CJC-1295 (no DAC) and Ipamorelin are being studied together for their combined effects on stimulating natural growth hormone release. This pairing targets complementary pathways involved in GH secretion, making it a focus in research exploring recovery, sleep quality, and body composition.
What Researchers Explore
- Pulsatile growth hormone release patterns
- Sleep quality and recovery mechanisms
- Lean body composition and fat metabolism
- Muscle recovery and performance pathways
- Skin, connective tissue, and repair processes
- Bone density and structural support
Technical Background
CJC-1295 (no DAC) is a modified growth hormone-releasing hormone (GHRH) analog designed to stimulate endogenous GH release in short, physiologic pulses without extended half-life binding. It acts on pituitary somatotroph cells to promote natural GH secretion via cAMP-mediated signaling pathways.
Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2) is a selective growth hormone secretagogue with a molecular weight of 711.9 Da. It acts on ghrelin receptors (GHS-R1a) to stimulate GH release with high specificity, demonstrating minimal interaction with other endocrine pathways such as ACTH, cortisol, prolactin, and FSH.
Together, this combination is studied for its ability to enhance physiologic GH pulses through dual-pathway activation, closely mimicking natural secretion patterns.
Common Research Applications
- Growth hormone secretion and regulation studies
- Pulsatile GH release pattern research
- Recovery and tissue repair pathway studies
- Endocrine selectivity and signaling research
- Growth hormone secretagogue structure-activity studies
- Metabolic and body composition research
Product Properties
Purity: 99%+ HPLC
Form: Lyophilized Powder
Size: 5mg / 5mg
Category: Growth Hormone Research Stack
Frequently Studied Together
- Ipamorelin (growth hormone secretagogue research)
- Sermorelin (GHRH analog research)
- Tesamorelin (GH pathway and fat metabolism research)
- IGF-1 LR3 (downstream growth factor signaling research)